eVTOL stocks stayed under pressure on June 13, but the more useful signal was how differently investors treated the three names inside the same weak tape. JOBY closed at $9.15 on 23,589,079 shares, ACHR closed at $5.08 on 27,997,582 shares, and EH closed at $6.63 on 1,050,552 shares; with the 10-year Treasury yield at 4.49% and Fed Funds at 3.63%, capital is still being priced against long-duration stories.
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Is JOBY’s smaller drawdown than ACHR a real leadership signal, or just a temporary mismatch with ARKX positioning?
The cleanest starting point is the tape itself. JOBY fell 2.24% while ACHR fell 4.15%, even though both companies are still pre-profit, still tied to certification timing, and still trading in the same high-rate environment. JOBY also held that relative edge with 23.6 million shares traded versus Archer’s 28.0 million, which matters because this was not a thin, low-conviction move. My read: when two similar story stocks trade heavy together and one consistently loses less, the market is quietly repricing execution credibility before passive ownership catches up.
That is where ARKX becomes interesting rather than decisive. The June 10 and June 11 holdings snapshots in the daily files still showed Archer ahead of Joby in ETF weight, with ACHR at 3.10% to 3.34% versus JOBY at 2.53% to 2.63%. Those numbers tell you how the fund was positioned, not what the next marginal buyer preferred on June 13. ETF weights are slow outputs of prior conviction. Price is the faster instrument. If the market now believes Joby’s operating stack deserves a higher quality multiple, that judgment will appear first in relative downside protection, not in an instant reshuffle of an ETF sleeve.
The source hierarchy also tilts in Joby’s favor. The stronger Joby-side evidence came from a direct operating comparison carried through Yahoo Finance’s republication of Motley Fool analysis, which highlighted the S4’s 150-mile range, 200 mph speed, Toyota manufacturing backing, Delta distribution potential, Uber app integration, and a $131 million Department of Defense contract. Archer’s visible tape, by contrast, was dominated by TipRanks caution on options protection and by repeated Form 144 stories from Timothysykes.com and StocksToTrade that framed near-term supply risk around insider or large-holder selling. The way I see it, one narrative is about strategic capacity and eventual monetization, while the other is about who may be selling into rallies right now.
That does not mean Joby has won the sector. Reuters- or Bloomberg-grade confirmation of a new certification step did not appear in this run, so I would not overstate the case. FAA certification data was unavailable this run; next check scheduled for 2026-06-14. Still, the current spread in daily performance suggests investors are placing a constructive lean on Joby relative to Archer. If JOBY keeps defending capital better across another few sessions, ARKX’s current weighting will start to look backward-looking rather than informative. Until that happens, I think the correct conclusion is narrower: price is hinting at an emerging leadership change, and the ETF has not validated it yet.
Why is ACHR trading like the market distrusts its setup even though ARKX still gives it the larger weight?
ACHR’s problem is that ownership and demand are not the same thing. The ETF can still hold Archer at 3.10%, but if discretionary buyers decide the path from certification to commercialization is stretching out, the stock can keep falling anyway. The June 13 technical data makes that argument hard to ignore. ACHR closed at $5.08 against an SMA5 of $5.30 and an SMA20 of $6.07, while RSI14 fell to 29.49. That combination says the stock is oversold, but it also says price remains below both short- and medium-term trend markers. My view is that oversold readings are evidence of pressure already absorbed, not proof that support has formed.
The raw coverage explains why that pressure is sticking. TipRanks described a more defensive options tone, with higher implied volatility and investors paying more for downside protection. Timothysykes.com and StocksToTrade both centered their stories on a Form 144 filing, emphasizing the risk that extra share supply could cap any bounce. Even the more optimistic Motley Fool argument, visible through Yahoo Finance, conceded that Archer still needs FAA Type Certification, Production Certification, and scaled operations before the billion-dollar revenue narrative becomes something investors can underwrite with confidence. In other words, the positive case still depends on future proof, while the negative case is immediate and mechanical.
The financial numbers reinforce that asymmetry. Archer’s raw articles cite about $951.1 million of cash, roughly $1.78 billion including short-term investments, and quarterly revenue of only about $1.6 million against a net loss around $217.7 million. Those figures are enough to describe runway, but not enough to create urgency to own the stock at this exact moment. Add a 4.49% 10-year yield and a 3.63% Fed Funds rate, and the market has every reason to discount distant cash flows more harshly. I think that macro backdrop is doing real work here: in a cheaper-money environment, investors might tolerate a longer proof curve; in this one, they are charging Archer for every unanswered step.
That is why the larger ARKX weight looks stale rather than supportive. The ETF still reflects theme exposure, but the market is applying a cautious lean because the near-term flow is shaped by supply risk, not by a fresh contract, rating upgrade, or regulatory milestone. A sharp bounce is still possible because RSI14 at 29.49 is deeply stretched, and oversold names can move violently when the news flow changes. But as of this run, I would treat that as tactical bounce potential, not evidence that Archer has repaired the underlying trust problem. Until ACHR reclaims trend levels instead of merely looking cheap below them, the heavier ETF weight is leftover positioning rather than a bullish signal.
What would EH need to prove for the gap between a $6.63 stock and $13 to $14 targets to stop looking like a credibility discount?
EH’s valuation gap is now too large to dismiss as ordinary volatility. The stock closed at $6.63, while the visible analyst frame still points to a $13.00 average target from Globe and Mail’s syndicated TipRanks snapshot and a $14.00 target from Deutsche Bank via MarketScreener after a cut from $17. That puts EH at roughly half of those reference points, which tells me the market is no longer debating upside optionality; it is debating whether management can convert certification progress into revenue quality before confidence erodes further. My read is skeptical in the near term, but not dismissive of the longer-term setup.
The operational trigger is revenue credibility. MSN’s headline framed the immediate issue clearly: EHang shares tumbled after a Q1 revenue miss and wider losses. That matters more than the target prices because sell-side targets can remain anchored to a multi-year thesis long after traders start marking down near-term execution. The June 13 technical picture confirms the damage. EH’s SMA5 was $7.13, its SMA20 was $8.94, and RSI14 was 28.57, which means the stock was oversold and still trading below both short- and medium-term trend levels. The market is not pricing a quick normalization; it is pricing another wait.
The next step is margin discipline and commercial conversion. Globe and Mail still cited a Moderate Buy consensus and Bank of America’s $13 target, so analysts have not abandoned the business model. But lower targets after weak results are a reminder that future value is being discounted more heavily when current evidence slips. I think investors need to see three things happen together: first, a cleaner revenue recovery after the Q1 miss; second, narrower losses that look operational rather than cosmetic; and third, more visible linkage between regulatory progress, production readiness, and actual commercial throughput. Without that sequence, the market can keep treating analyst targets as theoretical destination math rather than actionable valuation anchors.
There is also a comparative issue. Joby and Archer are being judged mainly on certification path and capital efficiency, but EHang is now being judged on whether it can turn those milestones into dependable sales. That makes the burden of proof higher, not lower. If the next reporting cycle shows better delivery against revenue expectations and a tighter loss profile, the stock has room to rerate sharply because the target gap is so wide. If not, the discount can persist despite supportive analyst language. For now the directional lean is cautious: EH does not need a new narrative, it needs operating evidence strong enough to make the $13 to $14 framework feel earned again.
What to Watch Tomorrow
- First, watch whether JOBY again loses less than ACHR in the next completed session, because another relative-strength print would strengthen the case that leadership is rotating before ETF positioning changes.
- Second, watch whether ACHR can reclaim its SMA5 area near $5.30, because failure to retake that level would keep the Form 144 overhang in control of the near-term tape.
- Third, watch whether EH stabilizes closer to its SMA5 than its RSI14 low, because that would be the first technical hint that the market is reassessing the post-earnings credibility discount.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: https://futurewatchlog.com/2026/06/12/evtol-daily-insight-2026-06-12/